528 / 1031
CTV L4-L3: 1-3 N+: INDICATIONS
The results are PENDING for these randomized trials :
RTOG 9915 (SWOG)
EORTC (SUPREMO – Selective Use of Postoperative Radiotherapy After Mastectomy): In
this trial apart from randomize 1 3 N(+) patients pT2 pN0 with grade 3 and/or
,
-
,
vasculo-lymphatic invasion were also randomized.
NCI CTG
French study
EBCTG META-ANALYSIS: POSITIVE RESULTS OF SURVIVAL 1-3 N+
11 5%
7 9%
.
.